Lexicon Pharmaceuticals, Inc.
LXRX
$0.3918
$0.02416.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.29% | 20.73% | 235.67% | 22.89% | 60.37% |
| Total Receivables | 810.38% | 282.48% | 484.67% | 3,507.14% | 715.38% |
| Inventory | 89.29% | 240.12% | -- | -- | -- |
| Prepaid Expenses | 56.28% | 25.33% | 109.35% | 106.77% | 52.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.25% | 21.66% | 232.87% | 25.33% | 60.63% |
|
|
|||||
| Total Current Assets | 20.25% | 21.66% | 232.87% | 25.33% | 60.63% |
| Net Property, Plant & Equipment | -8.63% | -15.60% | -16.53% | -11.41% | -3.19% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.44% | -- | -- | 100.97% | -- |
| Total Assets | 16.15% | 17.88% | 156.41% | 18.08% | 44.24% |
|
|
|||||
| Total Accounts Payable | 17.99% | 16.37% | -21.76% | 38.42% | 27.68% |
| Total Accrued Expenses | 8.50% | 0.34% | 60.12% | 38.13% | 148.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.77% | 0.00% | 0.00% | 0.00% | -8.18% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.73% | 6.77% | 14.86% | 36.14% | 74.90% |
|
|
|||||
| Total Current Liabilities | 11.73% | 6.77% | 14.86% | 36.14% | 74.90% |
| Long-Term Debt | 0.63% | 0.74% | 104.47% | 104.84% | 317.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.07% | -10.87% | -6.88% | -2.93% | 0.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.12% | 2.31% | 71.89% | 76.64% | 187.35% |
|
|
|||||
| Common Stock & APIC | 13.80% | 13.88% | 23.12% | 8.98% | 9.02% |
| Retained Earnings | -12.60% | -12.13% | -11.94% | -11.14% | -10.12% |
| Treasury Stock & Other | -42.29% | -61.07% | -53.05% | -14.66% | -17.48% |
| Total Common Equity | 27.96% | 28.77% | 228.06% | -20.50% | -3.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.96% | 28.77% | 228.06% | -20.50% | -3.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.96% | 28.77% | 228.09% | -20.50% | -3.13% |
|
|
|||||
